Project Grant HT94252510827
Award Date
10/1/25
Completion Date
9/30/28
Dollars Obligated
$663K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
The University of Texas Health Science Center at Houston (UTHealth) was awarded a $1,067,612 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "HOME NEUROMODULATION FOR NEUROGENIC BLADDER MANAGEMENT IN SPINAL CORD INJURY: A HYBRID IMPLEMENTATION-EFFECTIVENESS TRIAL", will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader...
The U.S. Department of Defense's Defense Health Agency has awarded a $1,400,000 Project Grant to The Methodist Hospital Research Institute (HMRI) in Houston, Texas under the Military Medical Research and Development (CFDA 12.420) program. The award, with a performance period from September 15, 2024 through September 14, 2027, will support the "Development of a Novel Therapeutic to Treat DNA Damage Associated with Atypical Burns". This project will focus on advanced biomedical...
The Department of Defense's Defense Health Agency awarded a $444,125 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Methodist Hospital Research Institute (HMRI) in Houston, Texas. The grant, titled "IDENTIFICATION OF LIAX BINDING PARTNERS FOR PREVENTING RESISTANCE", will fund advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will focus on...
The Defense Health Agency awarded a $1,332,764 Project Grant to Neurocreis, Inc. in College Station, TX under the Military Medical Research and Development (CFDA 12.420) program. The grant supports the "Therapeutic Development of NC101 for Promoting Neurological Recovery After Chronic SCI", with a performance period from July 1, 2025 to June 30, 2028. The funding will enable Neurocreis to conduct advanced biomedical research aimed at transforming healthcare for military service...
The U.S. Department of Defense's Defense Health Agency awarded a $323,000 Project Grant with a performance period from March 1, 2024 to February 28, 2026 to The Methodist Hospital Research Institute Division. This grant, funded under the Military Medical Research and Development program (CFDA 12.420), supports research to identify cardiac conduction system abnormalities in a myotonic dystrophy animal model using noninvasive techniques. The Methodist Hospital Research Institute has a track record...
Memorial Hermann Health System was awarded a $672,634 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2023 through August 2026 to understand interpersonal violence against individuals with spinal cord injuries and examine related psychosocial impacts. As a large non-profit health system and hospital, Memorial Hermann will leverage its expertise in trauma-focused healthcare, medical...
This federal Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), provides $1,749,465.00 to Bright Uro, Inc. to develop a catheter-free, extended-monitoring urodynamics device for quantitative, real-time bladder management in spinal cord-injured patients. The award period runs from July 1, 2024 to June 1, 2026. The goal of this project is to create an innovative medical device that can assist in the care and treatment...
The federal Project Grant award of $1,793,411 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Rehabilitation Institute of Chicago (doing business as Shirley Ryan AbilityLab), a non-profit hospital and research institute. The funding will support a research project titled "SAFETY AND EFFICACY OF AMPAKINES FOR IMPROVEMENT OF BLADDER FUNCTION IN INDIVIDUALS WITH SCI" over the period of July 1, 2024 to June 30,...
The University of Washington was awarded a $1,810,550 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 1, 2023 through September 30, 2026 to investigate early chemodenervation of the detrusor muscle to preserve bladder compliance and function over the long term following spinal cord injury. The Military Medical Research and Development program supports basic,...
The Defense Health Agency awarded a $3,977,103 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Washington University to conduct a 4-year clinical trial on nerve transfer surgeries to improve upper limb function and quality of life for patients with high-level cervical spinal cord injuries. The study aims to address critical information gaps on the use of nerve transfer procedures in this patient population. The project will be executed through a...